TRIM7 activators represent an eclectic assortment of chemicals that navigate various cellular pathways, poised to indirectly mediate the expression or activity of TRIM7. A primary exemplar is Retinoic acid, renowned for its influential role in gene transcription processes, suggesting a potential enhancement in TRIM7 expression. Diving into the realm of plant-derived compounds, Curcumin and Resveratrol draw attention. These phytochemicals have shown to modulate an array of signaling pathways, leading to their plausible association with TRIM7 activity.
5-Aza-2'-deoxycytidine and Trichostatin A, both manipulating gene expression through distinct mechanisms of DNA methylation and histone deacetylation, respectively, present themselves as potential candidates in the TRIM7 activation cascade. On a cellular messaging front, Ionomycin, an ionophore and PMA, an activator for protein kinase C, sketch a likely pathway of influence on TRIM7. Similarly, Etoposide's interplay with DNA topoisomerase II suggests a potential interaction, given the broad cellular responses to DNA damage. Sodium Butyrate, with its histone deacetylase inhibition capability, MG132, as a proteasome inhibitor, and Anisomycin, a MAPK pathway activator, round off the list.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates MAPK pathway which might have downstream effects on TRIM proteins including TRIM7. |